HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frederick, J. M. Articles by Baehr, W. Search for Related Content PubMed PubMed Citation Articles by Frederick, J. M. Articles by Baehr, W.

Mutant Rhodopsin Transgene Expression on a Null Background

¹ From the Moran Eye Center, University of Utah Health Science Center, Salt Lake City; the ² Department of Ophthalmology and the ³ Molecular Cardiology Research Institute, New England Medical Center, Boston, Massachusetts; ⁴ Charité–Virchow Augenklinik, Humboldt University, Berlin, Germany; and the ⁵ Program in Genetics, Tufts University School of Medicine, Boston, Massachusetts.

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
PURPOSE. To study mechanisms leading to photoreceptor degeneration in mouse models for autosomal dominant retinitis pigmentosa (adRP) based on the rhodopsin P23H mutation.

METHODS. Mice of a transgenic line expressing a rhodopsin triple mutant, V20G, P23H, and P27L (GHL), were mated with rhodopsin (rho) knockout mice. Littermates of various ages and genotypes (GHL⁺rho^+/+, GHL⁺rho^+/-, and GHL⁺rho^-/-) were examined for outer nuclear layer thickness and outer segment formation (histology), fate of mutant rhodopsin (immunocytochemistry), and photoreceptor function (electroretinogram; ERG).

RESULTS. Mice expressing GHL-rhodopsin in the absence of wild-type rhodopsin had severe retinopathy, which was nearly complete by postnatal day (P)30. GHL-rhodopsin formed homodimers nearly exclusively on sodium dodecyl sulfate–polyacrylamide gel electrophoresis gels, whereas wild-type rhodopsin predominantly formed monomers. Expression level of mutant rhodopsin in predegenerate (P10) GHL⁺rho^-/- retinas was low, approximately 10% to 25% of normal levels. No elaboration of disc membrane or outer segment formation was observed at any time point examined. The mutant rhodopsin was found mostly in perinuclear locales (endoplasmic reticulum; ER) as evidenced by colocalization using the antibodies Rho1D4 and calnexin-NT.

CONCLUSIONS. GHL-rhodopsin dimerizes, localizes to the ER, and fails to transport and support outer segment formation. Additionally, the mutant protein does not support a scotopic ERG a-wave and accelerates photoreceptor degeneration over that occurring with the rhodopsin knockout alone. These findings indicate a cytotoxic effect of the mutant protein, probably elicited by an unfolded protein response.

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
Rhodopsin is an abundant, multifunctional intrinsic membrane protein, acting as a photoreceptor molecule; a rod outer segment (ROS) structural protein; and, in its activated form, as a guanosine triphosphate–guanosine diphosphate exchange factor.¹ More than 80 mutations in the human rhodopsin gene are associated with the genetically heterogeneous group of retinal degenerations referred to as retinitis pigmentosa (RP).^{2 3 4} Rhodopsin mutants account for the largest proportion of autosomal dominant (ad) RP cases of known genetic origin (30%–40%).⁵ The first rhodopsin mutation identified, P23H,⁶ occurs most frequently in the United States. A transgenic mouse line bearing a single P23H mutation in the human rhodopsin gene accumulated mutant rhodopsin in the outer plexiform layer,⁷ indicating misrouting of the mutant protein.⁸ An independent transgenic mouse line expressing the rhodopsin mutations V20G, P23H, and P27L, produces a slowly progressing photoreceptor degeneration resembling human adRP.⁹ It has been suggested that on the wild-type background, GHL mutant rhodopsin incorporated into ROS disc membranes, but basal discs appeared disorganized.¹⁰ However, in vitro experiments, in which the P23H mutant protein was expressed in heterologous cells, showed low levels of expression and retention of the mutant protein in the ER.¹¹

In transgenic mouse models, the mutant rhodopsin transgenes were expressed on wild-type genetic backgrounds in which normal rhodopsin was also expressed. Molecular mechanisms by which expression of mutant rhodopsin leads to photoreceptor cell death explaining the dominant phenotype of retinal degeneration are not understood. Availability of rhodopsin knockout mice^{12 13} has made it possible to study mutant rhodopsin expressed in vivo isolated from wild-type rhodopsin. We generated mice expressing GHL-rhodopsin on rho^-/-, rho^+/-, and rho^+/+ backgrounds, compared the rates of retinal degeneration, determined whether the mutant protein alone was capable of supporting ROS formation, and localized the mutant protein. Severity of retinal degeneration was determined by the ratio of mutant to wild-type protein. The most severe disease phenotype occurred when the GHL transgene was expressed in the absence of wild-type rhodopsin. We were surprised to observe that the mutant rhodopsin alone was unable to support disc membrane or outer segment formation. Immunogold labeling of GHL⁺rho^-/- retina sections revealed mutant rhodopsin localized to perinuclear regions of the rod, together with calnexin, a resident ER protein and chaperone. These results are interpreted to suggest that the misfolded, nonfunctional mutant rhodopsin accumulates in the ER, a condition known to elicit unfolded protein response (UPR; reviewed in Reference ¹⁴ ), leading to apoptosis.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Genotyping
Transgenic and knockout mice were cared for in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and the guidelines of the University of Utah Committee on Animal Research. The transgene and wild-type rhodopsin gene were distinguished by differential restriction digestion of a 1.3-kb amplification product produced by primers W75 (5'-AGACTGACATGG GGAGGAATTC-3') and W11 (5'-GTGCCTGTGATCACAGCACTT-3').⁹ The presence of the targeted rhodopsin gene was detected by separate amplification of a 493-bp fragment from the neomycin (Neo) gene using primers Neo4 (5'-CGGGAGCGGCGATACCGTAAAGC-3') and Neo7 (5'-GAAGCGGGAAGGGACTGG CTGCTA-3').

Immunoblot Analysis of Transgene Expression Level
Retinas from postnatal day (P)10 mice were isolated in ice-cold phosphate-buffered saline (PBS), placed in tubes individually, frozen in liquid nitrogen, and kept at -80°C until used. Solubilization of retinas was achieved using a two-buffer process. To each tube, 92 µl of buffer 1 (2.8% sodium dodecyl sulfate [ SDS]; 15 µg/ml each of pepstatin, leupeptin, aprotinin; 0.1 mM phenylmethylsulfonyl fluoride [PMSF], and 2 mM EDTA in 0.09 M Tris-HCl [pH 6.8]) was added. The retinas were vortexed, allowed to rest for 1 minute, revortexed, and allowed to rest 20 minutes at room temperature. Then, 40 µl of buffer 2 (0.4% bromophenol blue and 4.7% ß-mercaptoethanol in 9.4% glycerol) and 8 µl of 10 mM Tris-HCl (pH 7.4) were added per tube, for a total volume of 140 µl per retina, at room temperature. Retinal homogenates of the same genotype and age were pooled, producing the stock for subsequent dilutions. Samples shown in Figure 1D contained 1:70 retina per lane, with the exception of GHL⁺rho^-/-, which contained 1:14 (Fig. 1 , set 1, lane 1), 1:140 (lane 2), and 1:70 retina (lane 3). Proteins were separated using 12.5% sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE; 50 minutes, 200 V),¹⁵ transferred electrophoretically onto nitrocellulose membrane (1 hour, 100 V), and probed using monoclonal antibody (mAb) Rho1D4¹⁶ (1:750) for 3 hours at room temperature.

View larger version (60K): [in this window] [in a new window]   Figure 1. Transgene, targeted rhodopsin gene, P10 histology and immunoblot analysis. (A) Mouse rhodopsin transgene containing mutations in exon 1. N, A deleted NcoI site, the restriction fragment length polymorphism (RFLP) used to identify GHL+ mice. Underneath, N-terminal sequence of mouse rhodopsin and amino acid substitutions (G, H, L) of the transgene. N2 and N15 are glycosylated in mature rhodopsin. (B) Targeted rhodopsin gene. The first 111 codons of exon 1, including the translational start, were replaced by a neomycin gene.13 (C) Retinas of four littermates and age-matched rho-/- and rho+/+ mice show comparable histology at day P10. Sections were stained with 1% methylene blue/azure II in sodium borate solution and photographed in superior regions equidistant from the optic nerve. RIS, rod inner segments; OPL, outer plexiform layer. Bar, 20 µm. (D) Immunoblot of P10 retina extracts probed with a C-terminus–directed mAb, Rho1D4. Six panels are from one blot, partitioned to illustrate with corresponding histology. Wild-type rhodopsin migrated predominantly as a monomer (40 kDa, rightmost panel), whereas the transgene product formed a dimer almost exclusively when isolated from wild-type rhodopsin (GHL+rho-/-, leftmost panel). Two monomeric species were visible faintly only when the sample was overloaded (lane 1, first panel). As expected, the rho-/- retinal extract was negative (fourth panel from left).

Electron Microscopic Immunocytochemistry
Nonosmicated P10 and P15 retinas were selected for immunocytochemistry using antibody Rho1D4 in a postembedding procedure. Thin sections were cut, placed on slot grids, etched 30 minutes with a 10% hydrogen peroxide solution, rinsed twice with 5 ml deionized water and once with Tris saline (0.1 M Tris-HCl, 0.87% NaCl [pH 7.5]). Blocking was achieved by incubating 1 hour in 10% normal goat serum in a solution of 0.1 M Tris-HCl, 0.5% Triton, 0.5% bovine serum albumin (BSA). The grids were washed with 10 ml Tris saline, then incubated 1 to 2 hours at room temperature in 25 µl of primary antibody (diluted 1:25) in Tris-Triton-BSA. After they were rinsed drop-wise with 15 ml Tris saline, the grids were incubated 1 hour in 15 nm gold-conjugated goat anti-mouse IgG (catalog number 15747; Ted Pella, Redding, CA) diluted 1:75 in Tris-Triton-BSA. The grids were washed in Tris saline, fixed 10 minutes in 0.1% glutaraldehyde-0.1 M Tris saline-Triton, rinsed in buffer followed by water, dried, and stained. Companion grids of each specimen were processed in parallel, omitting incubation in primary antibody, as negative controls. Inner nuclear layer (INL) and inner plexiform layer (IPL) regions (internal negative control) of each section were also examined to establish background levels of label. Application of the N-terminus–directed mAb Rho4D2¹ to companion grids rendered identical localizations of weaker signal strength (not shown).

Colocalization of calnexin and GHL-rhodopsin was achieved by simultaneous incubation with primary antibodies. Thin sections of P10 rho^-/- and GHL⁺rho^-/- retinas were placed on Formvar- (SPI) and carbon-coated gold slot grids. Calnexin-NT (catalog number SPA-865; StressGen Biotechnologies, Victoria, British Columbia, Canada), an antipeptide polyclonal antibody directed toward residues 50-68 of canine calnexin,¹⁸ was applied to sections for 1 hour before addition of Rho1D4 for 1 hour. After they were rinsed, the sections were incubated in Tris-Triton-BSA containing 5 nm gold-conjugated goat anti-rabbit IgG (catalog number 15725; Ted Pella) to detect calnexin-NT and 15 nm gold-conjugated goat anti-mouse IgG to detect RholD4.

Electroretinograms
Pupils of dark-adapted mice were dilated using 1% atropine-0.5% tropicamide, and animals were anesthetized subcutaneously with 20 mg xylazine and 40 mg ketamine per kilogram body weight. Electroretinograms (ERG)s were recorded using a monopolar corneal contact lens electrode (Medical Workshop, Groningen, The Netherlands). Silver reference and neutral electrodes were placed subcutaneously 3 mm below the eye and in the forehead, respectively. Mice were placed into a Ganzfeld bowl (Toennies Multiliner Vision, Höchberg, Germany). The Ganzfeld stimulus was a white flash with a color temperature of 6000° K and 50-µsec duration. For the scotopic ERG, eight flash energies from 4 x 10^-5 candelas (cd)/m² to 1 cd/m² were used. Because of the partly severe reduction of the rod responses, only the maximal scotopic ERG response (1 cd/m²) is presented. Two responses were averaged (interstimulus interval, 5 seconds). The curve was smoothed by a low-pass filter to obtain the b-wave minus oscillatory potentials. The oscillatory potentials were then recorded in a separate step using a 100- to 1000-Hz band-pass filter. For the photopic ERG, a 30-cd/m² background light was used. A single-flash response to a 15-cd/m² light flash was recorded (average of 16). Scotopic and photopic ERGs were repeated three times during each session to confirm stability. Final amplitude values were the mean of three determinations.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Onset of Retinal Degeneration in GHL⁺rho^-/- Mice
To measure severity of retinal degeneration in various genotypes, outer nuclear layer (ONL) thickness was compared with ONL thickness in age-matched normal mice (approximately 10–12 rows of photoreceptor nuclei in adult mice). Matings were arranged between GHL⁺rho^+/- and rho^+/- parental mice, agouti in pigmentation, to produce littermates expressing the mutant transgene on all backgrounds. One hundred twenty mice ranging in age from P10 to 7 months (P210) were examined. Inheritance followed Mendelian patterns—that is, the GHL transgene (Fig. 1A) was transmitted to approximately 50% of progeny, whereas the neomycin gene (Fig. 1B) , indicating presence of the rhodopsin knockout alleles, was transmitted to approximately 75% of pups. For all genotypes, the ONL and photoreceptor inner segments developed normally through P10 (Fig. 1C) . Onset of degeneration in GHL⁺rho^-/- mice occurred between P10 and P15, roughly coinciding with eye opening (P12), a time when rhodopsin gene expression significantly increases.¹⁹ Autophagic vacuoles were observed ultrastructurally in P10 GHL⁺rho^-/- retinas, although the ONL thickness still consisted of 10 rows.

Mutant and Wild-Type Rhodopsin Expression in Predegenerate Retina at P10
Previous experiments measuring RNA levels indicated that the GHL transgene contributed approximately 50% of total rhodopsin RNA in GHL⁺rho^+/+ retina.⁹ To estimate the amount of mutant rhodopsin in predegenerate GHL⁺rho^-/- retinas, Western blots were produced from P10 retinas of each genotype (Fig. 1D) . Dimer formation of normal rhodopsin is thought to result from temperature- and SDS-dependent aggregation during retinal extract preparation.²⁰ In contrast to normal rhodopsin, GHL-rhodopsin migrated predominantly as a dimer, whereas only trace amounts of monomeric species of GHL-rhodopsin were present (Fig. 1D , left lane). Scanning densitometry of two independent blots (not shown) estimated the amount of mutant rhodopsin produced in GHL⁺rho^-/- retinas to be 10% to 25% of wild-type values, or significantly less than predicted from RNA levels,⁹ suggesting that the mutant protein had a shorter half-life than normal rhodopsin (assuming equal translation rates of mutant and normal mRNAs). The results are consistent with an altered, less stable structure of mutant rhodopsin that defaults into a dimer in the presence of SDS.

Comparative Histopathology
Because ERG responses can be measured reliably in P30 mice, we assessed retina disease in littermates of this age. Consistent with earlier findings,¹³ the number of rows of photoreceptor nuclei in rho^-/-, rho^{+ /-}, and rho^+/+ mouse retinas were 9 to 10, 10, and 10 rows, respectively (Figs. 2D 2E 2F ). Retinas of these genotypes are distinguished by their differences in length of ROSs, which were absent in rho^-/- mice and were approximately 80% of wild-type length in rho^+/- mice. In contrast, the ONL of GHL⁺rho^-/- retinas were reduced to one to three rows of nuclei with no ROSs (Fig. 2A) . GHL⁺rho^+/- retinas revealed 4 to 5 rows of photoreceptor nuclei with severely truncated ROSs (Fig. 2B) , whereas GHL⁺rho^+/+ retinas exhibited 10 rows of photoreceptor nuclei with somewhat (40%) shortened ROSs (Fig. 2C) . Thus, expression of the mutant transgene on the rho^-/- background resulted in loss of approximately 80% of photoreceptor cells by P30.

View larger version (117K): [in this window] [in a new window]   Figure 2. Retinal histology of P30 littermates. Light micrographs. Transgene expression on null or haploid backgrounds revealed reduced ONL thicknesses (A, B). Conversely, presence of normal rhodopsin retarded the rate of degradation of rods that express the transgene (B, C compared with A). (G through L) Rod photoreceptor ultrastructure of phenotypes corresponding to (A) through (F). Open arrows: Connecting cilia. Transgene expression resulted in absent ROSs (G, rho-/- background), severely shortened ROSs (H, rho+/- background), and packets of disc membrane (I, rho+/+ background, ) apparently being sloughed near the ROS bases. Arrowhead: Site of membrane connection. Mitochondria were present in the inner segment of rho-/- retina (J, m), but mitochondria were scarce in GHL+rho-/- retina (G) where endoplasmic reticulum (er) formed concentric stacks surrounding the rod nucleus. PE, retinal pigmented epithelium; nu, nucleus.

Rhodopsin Immunolocalization
Confocal immunolocalization was performed to assess the subcellular distribution of GHL-rhodopsin at P10 and at P30 with mAb Rho1D4. At P10, retinas expressing GHL-rhodopsin (Figs. 3D 3E 3F ) had ONL thicknesses nearly equivalent to those of rho^-/-, rho^+/-, and rho^+/+ retinas (Figs. 3A 3B 3C) . However, comparison of Rho1D4 labeling on genetic backgrounds of two (Fig. 3F) , one (Fig. 3E) , or zero (Fig. 3D) wild-type rhodopsin alleles revealed progressive restriction of label to perinuclear regions of the proximal ONL. Thus, genetic removal of wild-type rhodopsin appeared to restrict the distribution of expressed transgene product in GHL⁺rho^-/- retina (Fig. 3D) . Later, P30 rho^+/- and rho^+/+ retinas revealed preferential ROS labeling (Figs. 3H 3I) , whereas rho^-/- retinas were negative (Fig. 3G) . In a GHL⁺rho^+/+ littermate retina, label was found mostly in truncated ROSs, but also in inner segments and perinuclear regions (Fig. 3L) . Relative to that of a rho^+/- littermate (Fig. 3H) , the ONL thickness of a GHL⁺rho^+/- retina was halved, and immunolabel was detectable in perinuclear regions and severely truncated ROSs (Fig. 3K) . Compared with P10 (Fig. 3D) , GHL⁺rho^-/- retina at P30 exhibited only slight labeling, because rapid degeneration had reduced the ONL thickness to one to three nuclear rows (Fig. 3L) . Cones were apparently spared from degeneration at P30, as evidenced by peanut agglutinin binding to extracellular cone sheaths, consistent with human RP phenotypes in which degenerative effects target rods initially. Collectively, these results suggest retention of GHL-rhodopsin, followed by degradation and rod degeneration.

View larger version (116K): [in this window] [in a new window]   Figure 3. Localization of fluorescein isothiocyanate (FITC)–labeled rhodopsin (green) versus binding of peanut agglutinin (red) in P10 age-matched mice (A through F) and P30 littermates (G through L). Rho1D4 recognized the C termini of wild-type and mutant rhodopsins in rod photoreceptors; peanut agglutinin binding revealed cone sheaths. Rho1D4 (1:500 dilution) was incubated with cryostat sections for 1 hour at room temperature. After they were rinsed, the sections were incubated with fluorescein-conjugated rabbit anti-mouse secondary antibody (1:100) and were photographed using a confocal microscope (x40 oil objective, optical slice 1.3 µm). Rho-/- retinas were nonreactive with Rho1D4 antibody, consistent with deletion of the rhodopsin gene (A). In the ONL of P10 GHL+rho-/- retina (D), rod perinuclear regions were specifically immunolabeled. Labeling of P10 rho+/+ retina (C) was, in contrast, predominantly that of ROS. Labeling of P30 rho+/+ retina (I) was that of ROS, whereas P30 GHL+rho-/- retina (J) showed slight specific label, owing to degeneration. FITC-fluorescence associated with sclera and capillaries of the OPL and choroid was nonspecific background. OS, outer segment; IS, inner segments.

View larger version (159K): [in this window] [in a new window]   Figure 4. Electron microscopic immunolocalization of transgene product in GHL+rho-/- mice. (A) Micrograph showing absence of ROS membrane and presence of a small sac distal to a connecting cilium (arrowhead) in P10 GHL+rho-/- retina. (B) Labeling of membrane situated between two P10 rod nuclei using Rho1D4 (arrow). (C) Low-power micrograph showing inner segments but absence of ROS disc membrane in P15 GHL+rho-/- retina. (D) Low-power micrograph showing, in contrast, extent of ROS () development in P15 rho+/+ littermate. (E) Rho1D4 labeling of ROS membrane in P15 rho+/+ retina. (F) In P15 GHL+rho-/- retina, connecting cilia were observed to end abruptly or in a membrane-containing sac; two gold particles overlying this example of a terminal sac are insignificant label over background levels. (G) Gold particle cluster (arrow) in perinuclear region of P15 GHL+rho-/- rod. PE, retinal pigmented epithelium; nu, nucleus.

View larger version (144K): [in this window] [in a new window]   Figure 5. Colocalization of calnexin and GHL-rhodopsin. Calnexin, an ER integral membrane protein, binds transiently to many newly synthesized glycoproteins. Calnexin exhibits prolonged binding to misfolded or incompletely folded proteins.34 GHL-rhodopsin contains N-linked glycosylation sites at N2 and N15, and would be predicted to interact directly with calnexin. (A) Immunogold (5 nm; arrowheads) showing localization of calnexin perinuclearly in P10 rho-/- photoreceptors. Colocalization (B, C) of Rho1D4 (15-nm gold, arrows) and calnexin (5-nm gold, arrowheads) is shown in P10 GHL+rho-/- rods.

View larger version (30K): [in this window] [in a new window]   Figure 6. Progression of retinal degeneration with age and correlative ERGs. (A) Plot of ONL thicknesses versus time in age-matched mice. Genotypes are indicated as follows: () Rho+/+; () rho+/-; (•) rho-/-; () GHL+rho+/+; () GHL+rho+/-; and () GHL+rho-/-. () represents a data point derived from Figure 4C (right) in Reference 13 . Each other data point derives from four or more mice generated in this study. (B) Plot of scotopic (rod-dominated) b-wave amplitudes versus time (stimulus strength, 1 cd/m2), measured from littermates. (C) Plot of photopic (cone) b-wave amplitudes versus time (stimulus strength, 15 cd/m2), recorded from littermates. Symbols in (B) and (C) defined as in (A).

	Discussion

Top Abstract Introduction Methods Results Discussion References

Second, once synthesized, the mutant protein is retained in the ER. In P10 GHL⁺rho^-/- retinas, intense rhodopsin-specific immunolabel was observed in perinuclear locales (Fig. 3) . Further, the predominant perinuclear localization coincided with calnexin localization. Rho^+/+ and rho^+/- retinas also exhibited perinuclear labeling, but only slightly, consistent with ongoing biosynthesis and transport to the ROS. Compartmentalization of mutant rhodopsin in nondisc membranes was inferred by early observation that extraction of GHL⁺rho^-/- retinas with 1% octylglucoside (a detergent that dissolves disc membranes readily) before SDS-PAGE failed to detect any mutant rhodopsin, whereas wild-type rhodopsin was readily detectable (not shown). Retention of GHL-rhodopsin would prevent its subsequent transport to and through the connecting cilium to support outer segment formation, a key role of normal rhodopsin.

Third, severity of retinal degeneration occurring with transgene expression is inversely correlated with wild-type rhodopsin gene copy number. As shown in Figure 6 , the degeneration was most severe in the absence of wild-type alleles, moderate in the presence of one wild-type allele, and least severe in the presence of two wild-type alleles. Although retinas from P30 rho^+/- mice were nearly identical with those of rho^+/+ mice and showed no decrease in ONL thickness (Figs. 2E 2F) , transgene expression on a rho^+/- background resulted in a 50% reduction in ONL thickness (Fig. 2B) . In rho^+/- mice, the ONL thickness was reduced by approximately 10% at P90 and by approximately 20% at P180 (Lem et al., unpublished results, 1998). Consequently, the 50% reduction in ONL thickness observed in GHL⁺rho^+/- retina and the 80% reduction observed in GHL⁺rho^-/- retina are consistent with accelerated degeneration occurring with transgene expression.

Fourth, the accelerated degeneration in GHL⁺rho^-/- retinas suggests inherent cytotoxicity of the mutant protein. In view of recent results in yeast and mammals, the cytotoxicity may be attributable to a UPR (reviewed in References ^{14 29 30} ). The UPR constitutes stress signaling from the ER lumen to the nucleus in response to accumulation of misfolded or unfolded polypeptides. By pathways imprecisely characterized in mammals, the UPR may induce transcription of additional chaperones (to assist folding), attenuation of translation (to prevent generation of more mutant protein), and mechanisms of protein degradation. Additional death-inducing signals are generated by the ER overload response (EOR). Also conceivable is that retention of mutant rhodopsin blocks the proteasome–ubiquitination pathway and thus triggers events culminating in apoptosis.³¹ ER retention is a feature common to several well-characterized diseases (e.g., cystic fibrosis), in which the mutant chloride channel F508-cystic fibrosis transmembrane conductance regulator (CFTR) misfolds and is unable to exit the ER.³² Other examples in which misfolding of a nascent polypeptide chain leads to disease include neurodegenerative polyglutamine diseases (e.g., Huntington’s disease), spinocerebellar ataxia (SCA), and spinobulbar muscular atrophy (SBMA), in which mutant proteins with poly(Q) expansions misfold, aggregate, misprocess, and gain cytotoxic functions not inherent to the normal proteins (reviewed in Reference ³³ ).

	Acknowledgements

 
The authors thank the laboratories of Helga Kolb and Robert Marc for expert advice and discussions, and Colin Barnstable and Robert Molday for generously providing rhodopsin antibodies.

	Footnotes

 
⁵ Present affiliation: Universitätsklinikum Eppendorf-Augenklinik, Hamburg, Germany.

Supported by Grants EY12008 (JL) and EY08123 (WB) from the National Eye Institute; Grant Ru 457/6-3 from Deutsche Forschungsgemeinschaft (KR); the Foundation Fighting Blindness (FFB; JL, WB); and a Center Grant of the FFB to the Department of Ophthalmology at the University of Utah. JL is the recipient of a Career Development Award and a James S. Adams Special Scholar’s Award from Research to Prevent Blindness (RPB). WB is the recipient of a Senior Investigator Award from RPB.

Submitted for publication October 27, 2000; accepted December 8, 2000.

Commercial relationships policy: N.

Corresponding author: Jeanne M. Frederick, John A. Moran Eye Center, University of Utah Health Science Center, 50 North Medical Drive, Salt Lake City, UT 84132. jfrederi{at}hsc.utah.edu

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Molday, RS (1998) Photoreceptor membrane proteins, phototransduction, and retinal degenerative diseases: The Friedenwald Lecture Invest Ophthalmol Vis Sci 39,2491-2513[Medline][Order article via Infotrieve]
2. Dryja, TP, Li, T. (1995) Molecular genetics of retinitis pigmentosa Hum Mol Genet 4,1739-1743[Abstract]
3. Inglehearn, CF (1998) Molecular genetics of human retinal dystrophies Eye 12(Pt 3b),571-579
4. Gregory–Evans, K, Bhattacharya, SS (1998) Genetic blindness: current concepts in the pathogenesis of human outer retinal dystrophies Trends Genet 14,103-108[Medline][Order article via Infotrieve]
5. University of Texas-Houston Health Science Center. The Retina Network (RetNet). Available at http://www.sph.uth.tmc.edu/RetNet/disease.htm. Accessed January 19, 2001.
6. Dryja, TP, McGee, TL, Reichel, E, et al (1990) A point mutation of the rhodopsin gene in one form of retinitis pigmentosa Nature 343,364-369[Medline][Order article via Infotrieve]
7. Olsson, JE, Gordon, JW, Pawlyk, BS, et al (1992) Transgenic mice with a rhodopsin mutation (Pro23His): a mouse model of autosomal dominant retinitis pigmentosa Neuron 9,815-830[Medline][Order article via Infotrieve]
8. Roof, DJ, Adamian, M, Hayes, A. (1994) Rhodopsin accumulation at abnormal sites in retinas of mice with a human P23H rhodopsin transgene Invest Ophthalmol Vis Sci 35,4049-4062[Abstract/Free Full Text]
9. Naash, MI, Hollyfield, JG, Al-Ubaidi, MR, Baehr, W. (1993) Simulation of human autosomal dominant retinitis pigmentosa in transgenic mice expressing a mutated murine opsin gene Proc Natl Acad Sci USA 90,5499-5504[Abstract/Free Full Text]
10. Liu, XR, Wu, TH, Stowe, S, et al (1997) Defective phototransductive disk membrane morphogenesis in transgenic mice expressing opsin with a mutated N-terminal domain J Cell Sci 110,2589-2597[Abstract]
11. Sung, C-H, Davenport, CM, Nathans, J. (1993) Rhodopsin mutations responsible for autosomal dominant retinitis pigmentosa: clustering of functional classes along the polypeptide chain J Biol Chem 268,26645-26649[Abstract/Free Full Text]
12. Humphries, MM, Rancourt, D, Farrar, GJ, et al (1997) Retinopathy induced in mice by targeted disruption of the rhodopsin gene Nat Genet 15,216-219[Medline][Order article via Infotrieve]
13. Lem, J, Krasnoperova, NV, Calvert, PD, et al (1999) Morphological, physiological, and biochemical changes in rhodopsin knockout mice Proc Natl Acad Sci USA 96,736-741[Abstract/Free Full Text]
14. Kaufman, RJ (1999) Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls Genes Dev 13,1211-1233[Free Full Text]
15. Laemmli, UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227,680-685[Medline][Order article via Infotrieve]
16. MacKenzie, D, Arendt, A, Hargrave, P, McDowell, JH, Molday, RS (1984) Localization of binding sites for carboxyl terminal specific anti- rhodopsin monoclonal antibodies using synthetic peptides Biochemistry 23,6544-6549[Medline][Order article via Infotrieve]
17. Frederick, JM, Krasnoperova, NV, Hoffmann, K, Baehr, W, Lem, J, Rüther, K. (1999) Retinal degeneration is accelerated when a mutant rhodopsin transgene is expressed on a haploid or null rhodopsin background Retinal Degenerative Diseases and Experimental Therapy ,105-115 Kluwer Academic/Plenum New York.
18. Wada, I, Rindress, D, Cameron, PH, et al (1991) SSR alpha and associated calnexin are major calcium binding proteins of the endoplasmic reticulum membrane J Biol Chem 266,19599-19610[Abstract/Free Full Text]
19. Al-Ubaidi, MR, Pittler, SJ, Champagne, MS, Triantafyllos, JT, McGinnis, JF, Baehr, W. (1990) Mouse opsin: gene structure and molecular basis of multiple transcripts J Biol Chem 265,20563-20569[Abstract/Free Full Text]
20. Hargrave, PA (1995) Future directions for rhodopsin structure and function Behav Brain Sci 18,403-414
21. Colley, NJ, Cassill, JA, Baker, EK, Zuker, CS (1995) Defective intracellular transport is the molecular basis of rhodopsin-dependent dominant retinal degeneration Proc Natl Acad Sci USA 92,3070-3074[Abstract/Free Full Text]
22. Hebert, DN, Simons, JF, Peterson, JR, Helenius, A. (1995) Calnexin, calreticulin, and Bip/Kar2p in protein folding Cold Spring Har Symp Quant Biol 60,405-415
23. Ware, FE, Vassilakos, A, Peterson, PA, Jackson, MR, Lehrman, MA, Williams, DB (1995) The molecular chaperone calnexin bindsGlc1Man9GlcNAc2 oligosaccharide as an initial step in recognizing unfolded glycoproteins J Biol Chem 270,4697-4704[Abstract/Free Full Text]
24. Molinari, M, Helenius, A. (2000) Chaperone selection during glycoprotein translocation into the endoplasmic reticulum Science 288,331-333[Abstract/Free Full Text]
25. Liu, X, Garriga, P, Khorana, HG (1996) Structure and function in rhodopsin: correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa Proc Natl Acad Sci USA 93,4554-4559[Abstract/Free Full Text]
26. Baker, EK, Colley, NJ, Zuker, CS (1994) The cyclophilin homolog NinaA functions as a chaperone, forming a stable complex in vivo with its protein target rhodopsin EMBO J 13,4886-4895[Medline][Order article via Infotrieve]
27. Ferreira, PA, Nakayama, TA, Pak, WL, Travis, GH (1996) Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin Nature 383,637-640[Medline][Order article via Infotrieve]
28. Kurada, P, Tonini, TD, Serikaku, MA, Piccini, JP, O’Tousa, JE (1998) Rhodopsin maturation antagonized by dominant rhodopsin mutants Vis Neurosci 15,693-700[Medline][Order article via Infotrieve]
29. Pahl, HL (1999) Signal transduction from the endoplasmic reticulum to the cell nucleus Physiol Rev 79,683-701[Abstract/Free Full Text]
30. Mori, K. (2000) Tripartite management of unfolded proteins in the endoplasmic reticulum Cell 101,451-454[Medline][Order article via Infotrieve]
31. Plemper, RK, Wolf, DH (1999) Retrograde protein translocation: eradication of secretory proteins in health and disease Trends Biochem Sci 24,266-270[Medline][Order article via Infotrieve]
32. Chang, XB, Cui, L, Hou, YX, et al (1999) Removal of multiple arginine-framed trafficking signals overcomes misprocessing of delta F508 CFTR present in most patients with cystic fibrosis Mol Cell 4,137-142[Medline][Order article via Infotrieve]
33. Lin, X, Cummings, CJ, Zoghbi, HY (1999) Expanding our understanding of polyglutamine diseases through mouse models Neuron 24,499-502[Medline][Order article via Infotrieve]
34. Danilczyk, UG, Cohen–Doyle, MF, Williams, DB (2000) Functional relationship between calreticulin, calnexin, and the endoplasmic reticulum luminal domain of calnexin J Biol Chem 275,13089-13097[Abstract/Free Full Text]

This article has been cited by other articles:

				T. S. Aleman, A. V. Cideciyan, A. Sumaroka, E. A. M. Windsor, W. Herrera, D. A. White, S. Kaushal, A. Naidu, A. J. Roman, S. B. Schwartz, et al. Retinal Laminar Architecture in Human Retinitis Pigmentosa Caused by Rhodopsin Gene Mutations Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1580 - 1590. [Abstract] [Full Text] [PDF]

				E. S. Lee and J. G. Flannery Transport of Truncated Rhodopsin and Its Effects on Rod Function and Degeneration Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2868 - 2876. [Abstract] [Full Text] [PDF]

				W. Baehr, S. Karan, T. Maeda, D.-G. Luo, S. Li, J. D. Bronson, C. B. Watt, K.-W. Yau, J. M. Frederick, and K. Palczewski The Function of Guanylate Cyclase 1 and Guanylate Cyclase 2 in Rod and Cone Photoreceptors J. Biol. Chem., March 23, 2007; 282(12): 8837 - 8847. [Abstract] [Full Text] [PDF]

				B. M. Tam and O. L. Moritz Characterization of Rhodopsin P23H-Induced Retinal Degeneration in a Xenopus laevis Model of Retinitis Pigmentosa. Invest. Ophthalmol. Vis. Sci., August 1, 2006; 47(8): 3234 - 3241. [Abstract] [Full Text] [PDF]

				A. Galy, M. J. Roux, J. A. Sahel, T. Leveillard, and A. Giangrande Rhodopsin maturation defects induce photoreceptor death by apoptosis: a fly model for RhodopsinPro23His human retinitis pigmentosa Hum. Mol. Genet., September 1, 2005; 14(17): 2547 - 2557. [Abstract] [Full Text] [PDF]

				F. Chan, A. Bradley, T. G. Wensel, and J. H. Wilson Knock-in human rhodopsin-GFP fusions as mouse models for human disease and targets for gene therapy PNAS, June 15, 2004; 101(24): 9109 - 9114. [Abstract] [Full Text] [PDF]

				D. K. Vaughan, S. F. Coulibaly, R. M. Darrow, and D. T. Organisciak A Morphometric Study of Light-Induced Damage in Transgenic Rat Models of Retinitis Pigmentosa Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 848 - 855. [Abstract] [Full Text] [PDF]

				A. E. Runker, U. Bartsch, K.-A. Nave, and M. Schachner The C264Y Missense Mutation in the Extracellular Domain of L1 Impairs Protein Trafficking In Vitro and In Vivo J. Neurosci., January 1, 2003; 23(1): 277 - 286. [Abstract] [Full Text] [PDF]

				Genetically Modified Animals in Endocrinology Endocr. Rev., August 1, 2002; 23(4): 594 - 597. [Full Text] [PDF]

				J. L. Wiggs The Human Genome Project and Eye Disease: Clinical Implications Arch Ophthalmol, November 1, 2001; 119(11): 1710 - 1711. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frederick, J. M. Articles by Baehr, W. Search for Related Content PubMed PubMed Citation Articles by Frederick, J. M. Articles by Baehr, W.